Inventor

VERHOEST PATRICK ROBERT

US47 patents

⚠️ This page may combine multiple inventors who share the name “VERHOEST PATRICK ROBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERHOEST PATRICK ROBERT

PFIZER

Pyrazolo[3,4-d]pyrimidine compounds

Nitrile-containing antiviral compounds

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors

Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors

Imidazopyridazine compounds

4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors

Azabenzimidazole compounds

Triazine derivatives

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors

N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides

6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors

Azabenzimidazole compounds

Tricyclic compounds and their use as phosphodiesterase inhibitors

Nitrile-containing antiviral compounds

Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders

Nitrile-containing antiviral compounds

Methods of use and combinations

N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides

Selective androgen receptor modulators

Heterocyclic spiro compounds as MAGL inhibitors

6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds

Triazine derivatives

Tricyclic compounds and their use as phosphodiesterase inhibitors

6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors

Triazine derivatives

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors

Imidazopyridazine compounds

1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors

Imidazopyridazine compounds

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

Combinations for treatment of NAFLD/NASH and related diseases

6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands

Cyclopropabenzofuranyl pyridopyrazinediones

KAT II inhibitors

N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-YL)-1,3-thiazol-4-YL] amides

Pyrrolo[2,3-d]pyrimidine derivatives

Pyrazolopyrimidine compounds

Heteroarylphenoxy benzamide kappa opioid ligands

HELAL CHRISTOPHER JOHN

Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders

CLAFFEY MICHELLE MARIE

Amino-heterocyclic compounds

PROULX-LAFRANCE CAROLINE

Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline